0 Σχόλια
0 Μοιράστηκε
220 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Targeted Oncology Therapies, Precision Medicine for Lung and Colorectal Cancer"Future of Executive Summary Asia-Pacific Kirsten Rat Sarcoma (KRAS) Market: Size and Share Dynamics Data Bridge Market Research analyses that the market is growing with a CAGR of 10.4% in the forecast period of 2021 to 2028 and is expected to reach 358.26 million by 2028. The Asia-Pacific Kirsten Rat Sarcoma (KRAS) report encompasses the key developments in the market with respect to the...0 Σχόλια 0 Μοιράστηκε 342 Views 0 Προεπισκόπηση
-
Clinical Oncology Next Generation Sequencing Market Growth Drivers and Restraints Impacting DemandExecutive Summary Clinical Oncology Next Generation Sequencing Market: Growth Trends and Share Breakdown CAGR Value Data Bridge Market Research analyses that the clinical oncology next generation sequencing market which was USD 592.56 million in 2021, would rocket up to USD 1825.30 million by 2029, and is expected to undergo a CAGR of 15.1% during the forecast period 2022 to 2029. The key...0 Σχόλια 0 Μοιράστηκε 182 Views 0 Προεπισκόπηση
-
New Zealand Clinical Oncology Next Generation Sequencing Market Scope, Segmentation, and Key Insights 2025–2032Executive Summary New Zealand Clinical Oncology Next Generation Sequencing Market Size and Share Across Top Segments CAGR Value New Zealand clinical oncology next generation sequencing market size was valued at USD 4.12 million in 2024 and is projected to reach USD 14.83 million by 2032, with a CAGR of 17.4% during the forecast period of 2025 to 2032. This New Zealand Clinical...0 Σχόλια 0 Μοιράστηκε 387 Views 0 Προεπισκόπηση
-
Oncology Biosimilar Monoclonal Antibodies Market Trends: Growth, Share, Value, Size, and Analysis By 2033"Executive Summary Oncology Biosimilar Monoclonal Antibodies Market Research: Share and Size Intelligence The global oncology biosimilar monoclonal antibodies market size was valued at USD 1.38 billion in 2025 and is expected to reach USD 2.79 billion by 2033, at a CAGR of 9.10% during the forecast period. The credible Oncology Biosimilar Monoclonal...0 Σχόλια 0 Μοιράστηκε 25 Views 0 Προεπισκόπηση
-
Veterinary Oncology Market Revenue Analysis: Growth, Share, Value, Size, and Insights By 2033"Detailed Analysis of Executive Summary Veterinary Oncology Market Size and Share The global veterinary oncology market size was valued at USD 1.73 billion in 2025 and is expected to reach USD 3.91 billion by 2033, at a CAGR of 10.70% during the forecast period The Veterinary Oncology report makes available the current and forthcoming technical and...0 Σχόλια 0 Μοιράστηκε 6 Views 0 Προεπισκόπηση
-
Pegylated Drugs: Advanced Biologics Delivery Rising at 5.48% CAGR Through 2033"Key Drivers Impacting Executive Summary PEGylated Drugs Market Size and Share The global PEGylated drugs market size was valued at USD 16.01 billion in 2025 and is expected to reach USD 24.53 billion by 2033, at a CAGR of 5.48% during the forecast period The large-scale PEGylated Drugs Market report presents the best market and business solutions to...0 Σχόλια 0 Μοιράστηκε 234 Views 0 Προεπισκόπηση
-
Topoisomerase-I Payload ADC Drugs Market Report: Market Dynamics, Segmentation Analysis, and Forecast Outlook"Executive Summary Topoisomerase-I Payload ADC Drugs Market Size and Share: Global Industry Snapshot The global Topoisomerase-I Payload ADC Drugs market size was valued at USD 4.88 billion in 2025 and is expected to reach USD 16.33 billion by 2033, at a CAGR of 16.30% during the forecast period The research and analysis carried out in this Topoisomerase-I...0 Σχόλια 0 Μοιράστηκε 28 Views 0 Προεπισκόπηση
-
Vincristine Market Growth Outlook with Pfizer & CiplaVincristine Market Growth Outlook with Pfizer and Cipla1 The Vincristine Market is poised for steady expansion over the forecast period, driven by rising cancer prevalence, improved access to chemotherapy drugs, and increasing focus on pediatric oncology. According to industry estimates, the market is anticipated to grow at a CAGR of 7.5% from 2026 to 2034, reflecting stable...0 Σχόλια 0 Μοιράστηκε 391 Views 0 Προεπισκόπηση
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)